Clinical Trial Update: GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance [Phase 4]

View source ↗

Summary

Phase 4 study comparing Truvada (tenofovir disoproxil fumarate + emtricitabine) or emtricitabine alone versus HAART interruption in HIV-infected patients with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtriva (emtricitabine)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 4 | Status: COMPLETED